Search research articles
Contact Us
Filters
Showing results (11-20 of 106) with videos related to
Page
of 11
Sort By:
Journal of Endocrinological Investigation
|
March 22, 2000
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy
A Benso, F Broglio, C Gottero, et al.
Journal of Endocrinological Investigation
|
March 22, 2000
Corticotroph and adrenal responsiveness to hCRH, hexarelin and ACTH in young and elderly subjects
R Giordano, E Arvat, B Maccagno, et al.
European Journal of Endocrinology
|
May 1, 1997
Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women
E Arvat, L Gianotti, F Broglio, et al.
Neuroendocrinology
|
October 12, 1999
Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease
E Arvat, J Ramunni, B Maccagno, et al.
Clinical Endocrinology
|
April 21, 1999
The IGF-I response to very low rhGH doses is preserved in human ageing
E Arvat, G Ceda, J Ramunni, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
February 24, 2001
Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span
E Ghigo, E Arvat, L Gianotti, et al.
European Journal of Endocrinology
|
June 28, 2000
Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans
E Arvat, B Maccagno, J Ramunni, et al.
Journal of Endocrinological Investigation
|
March 25, 1999
Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease
E Arvat, J Ramunni, R Giordano, et al.
Journal of Endocrinological Investigation
|
January 2, 2003
H9c2 cardiac muscle cells express insulin-like growth factor binding protein-3 (IGFBP-3)
R Granata, C Gauna, E Arnolfo, et al.
Neuroendocrinology
|
January 16, 1998
Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans
E Arvat, B Maccagno, J Ramunni, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 106) with videos related to
Sort By:
Page
of 11
Journal of Endocrinological Investigation
|
March 22, 2000
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy
A Benso, F Broglio, C Gottero, et al.
Journal of Endocrinological Investigation
|
March 22, 2000
Corticotroph and adrenal responsiveness to hCRH, hexarelin and ACTH in young and elderly subjects
R Giordano, E Arvat, B Maccagno, et al.
European Journal of Endocrinology
|
May 1, 1997
Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women
E Arvat, L Gianotti, F Broglio, et al.
Neuroendocrinology
|
October 12, 1999
Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease
E Arvat, J Ramunni, B Maccagno, et al.
Clinical Endocrinology
|
April 21, 1999
The IGF-I response to very low rhGH doses is preserved in human ageing
E Arvat, G Ceda, J Ramunni, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
February 24, 2001
Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span
E Ghigo, E Arvat, L Gianotti, et al.
European Journal of Endocrinology
|
June 28, 2000
Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans
E Arvat, B Maccagno, J Ramunni, et al.
Journal of Endocrinological Investigation
|
March 25, 1999
Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease
E Arvat, J Ramunni, R Giordano, et al.
Journal of Endocrinological Investigation
|
January 2, 2003
H9c2 cardiac muscle cells express insulin-like growth factor binding protein-3 (IGFBP-3)
R Granata, C Gauna, E Arnolfo, et al.
Neuroendocrinology
|
January 16, 1998
Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans
E Arvat, B Maccagno, J Ramunni, et al.
Page
of 11